Navigation Links
Avanir Pharmaceuticals Announces Appointment of William Sibold as Chief Commercial Officer
Date:4/11/2011

NUEDEXTA can interact with other medications causing significant changes in blood levels of those medications and/or NUEDEXTA.  NUEDEXTA is contraindicated in patients receiving drugs that both prolong QT interval and are metabolized by CYP2D6 (e.g., thioridazine and pimozide) and should not be used concomitantly with other drugs containing quinidine, quinine, or mefloquine.  NUEDEXTA is contraindicated in patients taking monoamine oxidase inhibitors (MAOIs) or in patients who have taken MAOIs within the preceding 14 days.  NUEDEXTA is contraindicated in patients with a known hypersensitivity to its components.

NUEDEXTA may cause serious side effects, including possible changes in heart rhythm.  NUEDEXTA is contraindicated in patients with a prolonged QT interval, congenital long QT syndrome or a history suggestive of torsades de pointes, in patients with heart failure as well as patients with, or at risk of, complete atrioventricular (AV) block, unless the patient has an implanted pacemaker.

NUEDEXTA causes dose-dependent QTc prolongation.  When initiating NUEDEXTA in patients at risk of QT prolongation and torsades de pointes, electrocardiographic (ECG) evaluation of QT interval should be conducted at baseline and 3-4 hours after the first dose.

The most common adverse reactions in patients taking NUEDEXTA are diarrhea, dizziness, cough, vomiting, weakness, swelling of feet and ankles, urinary tract infection, flu, elevated liver enzymes, and flatulence.

NUEDEXTA may cause dizziness.  Precautions to reduce the risk of falls should be taken, particularly for patients with motor impairment affecting gait or a history of falls.

Patients should take NUEDEXTA exactly as prescribed.  Patients should not take more than 2 capsules in a 24- hour period, make sure that there is an approximate 12-hour interval between doses, and not take a double dose after they miss a dose.

These are not al
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Avanir Pharmaceuticals to Present Data at the American Academy of Neurology Annual Meeting
2. Avanir Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
3. Avanir Pharmaceuticals to Present at Three Conferences in March
4. AVANIR Pharmaceuticals Appoints Gregory J. Flesher to Senior Vice President and Chief Business Officer
5. AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results
6. AVANIR Pharmaceuticals Invites Investors to Fiscal 2011 First Quarter Conference Call
7. AVANIR Pharmaceuticals Announces NASDAQ Opening Bell Ceremony
8. AVANIR Pharmaceuticals Announces Pricing of Public Offering of Common Stock
9. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
10. AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
11. AVANIR Pharmaceuticals to Present at the UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... , July 29, 2014 Regado Biosciences, ... focused on the Phase 3 clinical development of Revolixys™ ... antithrombotic drug system, today announced that it will hold ... Aug. 12, 2014, at 8:30 a.m. EDT to discuss ... Interested participants and investors may access the ...
(Date:7/29/2014)... Edwards Lifesciences Corporation (NYSE: EW ), ... hemodynamic monitoring, today reported net income for the quarter ended ... share, and non-GAAP net income of $94.0 million, or $0.88 ... year earlier was $93.3 million, or $0.81 per diluted share, ... diluted share.  Net sales for the quarter ...
(Date:7/29/2014)... 2014 New technology in the form of ... to see and assess brain tissue more clearly while ... authors who released their findings today at the Society ... in Colorado Springs, CO. ... neurointervention, a specialty that facilitates stroke treatment by navigating ...
Breaking Medicine Technology:Regado Biosciences to Provide Second Quarter 2014 Financial Results and Corporate Highlights 2Regado Biosciences to Provide Second Quarter 2014 Financial Results and Corporate Highlights 3Edwards Lifesciences Reports Strong Second Quarter Results 2Edwards Lifesciences Reports Strong Second Quarter Results 3Edwards Lifesciences Reports Strong Second Quarter Results 4Edwards Lifesciences Reports Strong Second Quarter Results 5Edwards Lifesciences Reports Strong Second Quarter Results 6Edwards Lifesciences Reports Strong Second Quarter Results 7Edwards Lifesciences Reports Strong Second Quarter Results 8Edwards Lifesciences Reports Strong Second Quarter Results 9Edwards Lifesciences Reports Strong Second Quarter Results 10Edwards Lifesciences Reports Strong Second Quarter Results 11Edwards Lifesciences Reports Strong Second Quarter Results 12Edwards Lifesciences Reports Strong Second Quarter Results 13Edwards Lifesciences Reports Strong Second Quarter Results 14Edwards Lifesciences Reports Strong Second Quarter Results 15Edwards Lifesciences Reports Strong Second Quarter Results 16Edwards Lifesciences Reports Strong Second Quarter Results 17Edwards Lifesciences Reports Strong Second Quarter Results 18Edwards Lifesciences Reports Strong Second Quarter Results 19Edwards Lifesciences Reports Strong Second Quarter Results 20Edwards Lifesciences Reports Strong Second Quarter Results 21Edwards Lifesciences Reports Strong Second Quarter Results 22Edwards Lifesciences Reports Strong Second Quarter Results 23Edwards Lifesciences Reports Strong Second Quarter Results 24Edwards Lifesciences Reports Strong Second Quarter Results 25New Technology May Improve Visualization Of The Brain During Stroke Treatment 2New Technology May Improve Visualization Of The Brain During Stroke Treatment 3
... July 13, 2011 ,   , ... quarter of 2011 Adjusted EBITDA margin is 19.8 ... Successful conclusion of refinancing , ... and healthcare industry, has closed successfully the second,quarter of the 2011 financial ...
... Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ ) today ... webcast on Thursday, July 28, 2011 at 4:30 p.m. Eastern ... provide a business and financial update and review second quarter ... release may be accessed from the Investors section of the ...
Cached Medicine Technology:Gerresheimer Reports Strong Revenues and Earnings Growth in the Second Quarter 2
(Date:7/29/2014)... The Board of Governors of the State Bar ... Connie Akridge to serve as a trustee of ... the Foundation. Akridge served as President of the State Bar ... Holland & Hart in Las Vegas, providing tailored counsel on ... and healthcare clients for more than 25 years. She regularly ...
(Date:7/29/2014)... D.C. (PRWEB) July 29, 2014 New ... in Medicare Part D by a projected $2.9 to ... by the actuarial firm Milliman released today by the ... Part D premiums could increase by as much as ... hepatitis C drugs, including Sovaldi and Olysio. , The ...
(Date:7/29/2014)... 2014 The Law Offices of Michael Cordova ... Hope, a non-profit organization providing grief camps for kids, teens, ... and suffering our clients experience from the death of a ... an organization like Stepping Stones of Hope, as they provide ... Stones of Hope also includes a monthly support group and ...
(Date:7/29/2014)... headache sufferers to record the severity and regularity of ... Griffith research study. , A new approach to the ... with their triggers and is being led by Professor ... Health program. , He has developed an approach designed ... their headaches called Learning to Cope with Triggers (LCT). ...
(Date:7/29/2014)... cure most cases of cancer is to surgically remove ... is that the surgeon may fail to extract the ... a new technique, researchers at the University of Pennsylvania ... the entire tumor in the patient, increasing the likelihood ... injectable dye that accumulates in cancerous tissues much more ...
Breaking Medicine News(10 mins):Health News:Holland & Hart LLP Attorney Connie Akridge Reappointed Trustee of the Nevada Bar Foundation 2Health News:New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015 2Health News:The Law Offices of Michael Cordova is Sponsoring Stepping Stones of Hope, a Non-Profit Organization Providing Grief Camps for Kids, Teens, Adults, and Families 2Health News:Penn team makes cancer glow to improve surgical outcomes 2Health News:Penn team makes cancer glow to improve surgical outcomes 3
... Both Jim Himes and,Rep. Chris Shays, candidates for US ... pledge to support a comprehensive,strategy to fight HIV/AIDS in ... of Connecticut are HIV-positive, and in 2006 there,were 422 ... the US,Centers for Disease Control. Approximately 56,000 people are ...
... PLYMOUTH MEETING, Pa., Oct. 29 Genaera,Corporation ... development partner,MedImmune, Inc. presented interim Phase 2a ... interleukin-9 (IL-9) in adults with mild,persistent asthma, ... meeting held,October 25-30 in Philadelphia, Pennsylvania., ...
... 29 The holiday season is here,which for most ... in homes bustling with family and friends. All of ... increased risk for contracting,viruses, particularly influenza. Maxim Health Systems ... they have not already done so, not only,to protect ...
... Skin Enterprises,Inc. (NYSE: NUS ) today announced ... million, a 7 percent improvement over the prior-year,period. ... improvement over the,same quarter of 2007. Revenue for ... currency fluctuations and earnings per share were,negatively impacted ...
... this year,s liver meeting in San ... Oct. 29 Two studies presented at the,annual meeting of ... different picture of survival based on racial group for adult ... College of Medicine used a United Network for,Organ Sharing dataset ...
... BEIJING, Oct. 29 /Xinhua-PRNewswire-FirstCall/ -- China Medical,Technologies, ... a leading China-based,medical device company that develops, ... today announced that it will be attending ... November 5, 2008, Location: Beijing, China, ...
Cached Medicine News:Health News:House Candidates Jim Himes and Chris Shays Pledge Action on HIV/AIDS Epidemic 2Health News:Phase 2a Data for MEDI-528 Presented at CHEST 2008 2Health News:Give the Gift of Good Health This Holiday Season - Remind Friends and Family to Get a Flu Shot 2Health News:Give the Gift of Good Health This Holiday Season - Remind Friends and Family to Get a Flu Shot 3Health News:Nu Skin Enterprises Reports Third-Quarter 2008 Results 2Health News:Nu Skin Enterprises Reports Third-Quarter 2008 Results 3Health News:Nu Skin Enterprises Reports Third-Quarter 2008 Results 4Health News:Nu Skin Enterprises Reports Third-Quarter 2008 Results 5Health News:Nu Skin Enterprises Reports Third-Quarter 2008 Results 6Health News:Nu Skin Enterprises Reports Third-Quarter 2008 Results 7Health News:Nu Skin Enterprises Reports Third-Quarter 2008 Results 8Health News:Nu Skin Enterprises Reports Third-Quarter 2008 Results 9Health News:Nu Skin Enterprises Reports Third-Quarter 2008 Results 10Health News:Nu Skin Enterprises Reports Third-Quarter 2008 Results 11Health News:No Difference in Rate of Survival for Children of Different Races Undergoing Liver Transplantation, but Long-Term Results Not as Good for African-American Adults 2Health News:No Difference in Rate of Survival for Children of Different Races Undergoing Liver Transplantation, but Long-Term Results Not as Good for African-American Adults 3
Used for retrograde positioning of a ureteral stent. The radiopaque band improves fluoroscopic visibility of the positioner tip. Supplied sterile in peel-open packages. Intended for one-time use....
... silicone or Silitek, ACMI Single J ... healing after surgery. Following cystectomy, the ... supports the ileal intestinal anastomosis, and ... leakage. Following ureteroscopy, the Single J ...
... for interoperative placement to stent ... construction and continent urinary diversions. ... Intended for one-time use. CAUTION: ... must not remain indwelling more ...
... Electrode provides ablation and hemostasis to minimize ... procedures. The V-Max Roller Bar electrode has ... have circular edges for high current density ... was developed to provide a smoother area ...
Medicine Products: